Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Cose

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Pediatric Research|March 6, 2021
Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomesRaymand Pang, Brian M Mujuni, Kathryn A Martinello, et al.
BMJ Open|February 17, 2021
Effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on immune responses to vaccines among rural Ugandan adolescents: randomised controlled trial protocol B for the '<u>POP</u>ulation differences in <u>VAC</u>cine responses' (POPVAC) programmeAgnes Natukunda, Gyaviira Nkurunungi, Ludoviko Zirimenya, et al.
The Journal of Infectious Diseases|September 9, 2024
A Longitudinal Analysis of Memory Immune Responses in Convalescent Crimean-Congo Hemorrhagic Fever Survivors in UgandaCourtney A Cohen, Stephen Balinandi, Ana I Kuehne, et al.
The Lancet. Infectious Diseases|November 28, 2023
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trialAnne Wajja, Beatrice Nassanga, Agnes Natukunda, et al.
The Lancet. Infectious Diseases|January 6, 2024
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis controlAnne Wajja, Beatrice Nassanga, Agnes Natukunda, et al.
BMJ Open|February 17, 2021
Impact of BCG revaccination on the response to unrelated vaccines in a Ugandan adolescent birth cohort: randomised controlled trial protocol C for the 'POPulation differences in VACcine responses' (POPVAC) programmeLudoviko Zirimenya, Gyaviira Nkurunungi, Jacent Nassuuna, et al.
The Lancet. Global Health|October 18, 2024
Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trialsAgnes Natukunda, Gyaviira Nkurunungi, Ludoviko Zirimenya, et al.
Malaria Journal|February 26, 2021
Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensityStephen Tukwasibwe, James A Traherne, Olympe Chazara, et al.
BMJ Open|February 17, 2021
Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the '<u>POP</u>ulation differences in <u>VAC</u>cine responses' (POPVAC) programmeGyaviira Nkurunungi, Ludoviko Zirimenya, Jacent Nassuuna, et al.
The Lancet. Global Health|October 18, 2024
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trialJacent Nassuuna, Ludoviko Zirimenya, Gyaviira Nkurunungi, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Pediatric Research|March 6, 2021
Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomesRaymand Pang, Brian M Mujuni, Kathryn A Martinello, et al.
BMJ Open|February 17, 2021
Effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on immune responses to vaccines among rural Ugandan adolescents: randomised controlled trial protocol B for the '<u>POP</u>ulation differences in <u>VAC</u>cine responses' (POPVAC) programmeAgnes Natukunda, Gyaviira Nkurunungi, Ludoviko Zirimenya, et al.
The Journal of Infectious Diseases|September 9, 2024
A Longitudinal Analysis of Memory Immune Responses in Convalescent Crimean-Congo Hemorrhagic Fever Survivors in UgandaCourtney A Cohen, Stephen Balinandi, Ana I Kuehne, et al.
The Lancet. Infectious Diseases|November 28, 2023
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trialAnne Wajja, Beatrice Nassanga, Agnes Natukunda, et al.
The Lancet. Infectious Diseases|January 6, 2024
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis controlAnne Wajja, Beatrice Nassanga, Agnes Natukunda, et al.
BMJ Open|February 17, 2021
Impact of BCG revaccination on the response to unrelated vaccines in a Ugandan adolescent birth cohort: randomised controlled trial protocol C for the 'POPulation differences in VACcine responses' (POPVAC) programmeLudoviko Zirimenya, Gyaviira Nkurunungi, Jacent Nassuuna, et al.
The Lancet. Global Health|October 18, 2024
Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trialsAgnes Natukunda, Gyaviira Nkurunungi, Ludoviko Zirimenya, et al.
Malaria Journal|February 26, 2021
Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensityStephen Tukwasibwe, James A Traherne, Olympe Chazara, et al.
BMJ Open|February 17, 2021
Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the '<u>POP</u>ulation differences in <u>VAC</u>cine responses' (POPVAC) programmeGyaviira Nkurunungi, Ludoviko Zirimenya, Jacent Nassuuna, et al.
The Lancet. Global Health|October 18, 2024
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trialJacent Nassuuna, Ludoviko Zirimenya, Gyaviira Nkurunungi, et al.
Pageof 10